LEVERAGE LONG - ARGENX SE Share Price

Certificat

H897S

DE000SV167L8

Market Closed - Euronext Paris 11:37:51 29/05/2024 am IST
1.327 EUR -2.21% Intraday chart for LEVERAGE LONG - ARGENX SE
Current month-14.11%
1 month-13.79%
Date Price Change
29/24/29 1.327 -2.21%
28/24/28 1.357 -4.91%
27/24/27 1.427 +5.86%
24/24/24 1.348 +0.67%
23/24/23 1.339 -3.04%

Real-time Euronext Paris

Last update May 29, 2024 at 11:37 am IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ARGENX SE
IssuerLogo Issuer Société Générale Société Générale
H897S
ISINDE000SV167L8
Date issued 17/03/2023
Maturity Unlimited
Parity 1 : 1
Emission price 50.63
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 118.7
Lowest since issue 1.127
Spread 0.039
Spread %2.83%

Company Profile

argenx SE is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx SE aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx SE is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx SE is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx SE has offices in Belgium, the United States, and Japan.
Sector
-
More about the company

Ratings for argenx SE

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: argenx SE

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
337.7 EUR
Average target price
436.6 EUR
Spread / Average Target
+29.28%
Consensus
  1. Stock Market
  2. Certificates
  3. H897S Certificat